Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts through regulation of the HOXA6/ZBTB12 axis
Cancer-associated fibroblasts (CAFs) play critical roles in the tumor microenvironment and exert tumor-promoting or tumor-retarding effects on cancer development. Astragaloside IV has been suggested to rescue the pathological impact of CAFs in gastric cancer. This study aimed to investigate the pote...
Saved in:
Main Authors: | Liu Haibo, Luo Shicheng, Sha Xiaofeng, Chen Zhiping, Yang Dongdong |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2023-09-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2023-0033 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Astragaloside IV inhibits atherosclerosis caused by ferritin autophagy in a lipid deposition environment by activating Nrf2
by: Dandan Liu, et al.
Published: (2025-03-01) -
Astragaloside IV attenuates cadmium induced nephrotoxicity in rats by activating Nrf2
by: Yuchen Li, et al.
Published: (2025-01-01) -
The gut–kidney axis is regulated by astragaloside IV to inhibit cyclosporine A-induced nephrotoxicity
by: Cong Han, et al.
Published: (2025-01-01) -
Identification of HOXA9 methylation as an epigenetic biomarker predicting prognosis and guiding treatment choice in acute myeloid leukemia
by: Fei Xie, et al.
Published: (2025-02-01) -
Case report: Novel multi-exon homozygous deletion of ZBTB24 causes immunodeficiency, centromeric instability, and facial anomalies syndrome 2
by: Yan Long, et al.
Published: (2025-01-01)